$MYSZ
My Size, Inc.

2012 Q2 Form 10-Q Financial Statement

#000117891312001510 Filed on May 17, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2012 Q1 2011 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $300.0K $310.0K -$360.0K
YoY Change 500.0% 933.33% -376.92%
% of Gross Profit
Research & Development $30.00K 297.0K ILs $340.0K
YoY Change -40.0% -25.38%
% of Gross Profit
Depreciation & Amortization $10.00K 13.00K ILs $0.00
YoY Change 62.5% -100.0%
% of Gross Profit
Operating Expenses $330.0K 1.475M ILs -$20.00K
YoY Change 230.0% 184.2% -115.38%
Operating Profit -1.475M ILs
YoY Change 184.2%
Interest Expense -$30.00K $10.00K -$30.00K
YoY Change -250.0%
% of Operating Profit
Other Income/Expense, Net $0.00 46.00K ILs -$4.660M
YoY Change 53.33%
Pretax Income -$360.0K -$380.0K -$4.670M
YoY Change 260.0% 171.43% 4145.45%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$360.0K -1.429M ILs -$4.640M
YoY Change 260.0% 192.23% 4118.18%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$6.00 -$6.33 -$154.70
COMMON SHARES
Basic Shares Outstanding 23.81M 23.81M 11.65M
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q2 2012 Q1 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.00K $20.00K $240.0K
YoY Change -80.0% -33.33% -7.69%
Cash & Equivalents $10.00K 90.00K ILs 929.0K ILs
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $60.00K $90.00K $110.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $70.00K 420.0K ILs 1.340M ILs
YoY Change -53.33% 281.82% 27.01%
LONG-TERM ASSETS
Property, Plant & Equipment $50.00K 217.0K ILs 225.0K ILs
YoY Change -28.57% 210.0% 181.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $50.00K 217.0K ILs 225.0K ILs
YoY Change -28.57% 171.25% -16.04%
TOTAL ASSETS
Total Short-Term Assets $70.00K 420.0K ILs 1.340M ILs
Total Long-Term Assets $50.00K 217.0K ILs 225.0K ILs
Total Assets $120.0K 637.0K ILs 1.565M ILs
YoY Change -45.45% 235.26% 18.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $480.0K $470.0K $420.0K
YoY Change 700.0% 571.43% 223.08%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $60.00K $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.010M 3.061M ILs 2.933M ILs
YoY Change 1583.33% 4272.86% 539.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $70.00K $70.00K $60.00K
YoY Change -30.0% -22.22% -33.33%
Total Long-Term Liabilities $70.00K 185.0K ILs 177.0K ILs
YoY Change -69.57% 105.56% -82.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.010M 3.061M ILs 2.933M ILs
Total Long-Term Liabilities $70.00K 185.0K ILs 177.0K ILs
Total Liabilities $1.090M 3.246M ILs 3.110M ILs
YoY Change 275.86% 1928.75% 107.61%
SHAREHOLDERS EQUITY
Retained Earnings -11.59M ILs -10.16M ILs
YoY Change 11.43%
Common Stock 93.00K ILs 87.00K ILs
YoY Change 128.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$970.0K -2.609M ILs -1.545M ILs
YoY Change
Total Liabilities & Shareholders Equity $120.0K 637.0K ILs 1.565M ILs
YoY Change -45.45% 235.26% 18.29%

Cashflow Statement

Concept 2012 Q2 2012 Q1 2011 Q4
OPERATING ACTIVITIES
Net Income -$360.0K -1.429M ILs -$4.640M
YoY Change 260.0% 192.23% 4118.18%
Depreciation, Depletion And Amortization $10.00K 13.00K ILs $0.00
YoY Change 62.5% -100.0%
Cash From Operating Activities -$90.00K -938.0K ILs -$100.0K
YoY Change 0.0% 14.81% -70.59%
INVESTING ACTIVITIES
Capital Expenditures $0.00 5.000K ILs
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $170.0K
YoY Change -383.33%
Cash From Investing Activities $0.00 -5.000K ILs $170.0K
YoY Change -383.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net 104.0K ILs
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.00K 104.0K ILs 180.0K
YoY Change -20.0% -75.34%
NET CHANGE
Cash From Operating Activities -90.00K -938.0K ILs -100.0K
Cash From Investing Activities 0.000 -5.000K ILs 170.0K
Cash From Financing Activities 80.00K 104.0K ILs 180.0K
Net Change In Cash -10.00K -839.0K ILs 250.0K
YoY Change -200.0% 2.69% -24.24%
FREE CASH FLOW
Cash From Operating Activities -$90.00K -938.0K ILs -$100.0K
Capital Expenditures $0.00 5.000K ILs
Free Cash Flow -$90.00K -943.0K ILs
YoY Change 0.0% 15.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 dei Amendment Flag
AmendmentFlag
false
CY2012Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2012Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q1 dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
CY2012Q1 dei Document Type
DocumentType
10-Q
CY2012Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001211805
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23814428
CY2012Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012Q1 dei Entity Registrant Name
EntityRegistrantName
TOPSPIN MEDICAL INC
CY2011 topmd Recapitalization Of Equity Upon Reverse Acquisition
RecapitalizationOfEquityUponReverseAcquisition
595000 ILS
CY2012Q1 topmd Recapitalization Of Equity Upon Reverse Acquisition
RecapitalizationOfEquityUponReverseAcquisition
ILS
CY2011Q1 topmd Recapitalization Of Equity Upon Reverse Acquisition
RecapitalizationOfEquityUponReverseAcquisition
ILS
topmd Recapitalization Of Equity Upon Reverse Acquisition
RecapitalizationOfEquityUponReverseAcquisition
595000 ILS
CY2011Q1 topmd Stock Issued During Period Recapitalization Of Equity Upon Reverse Acquisition
StockIssuedDuringPeriodRecapitalizationOfEquityUponReverseAcquisition
-1186000 ILS
CY2011 topmd Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
9967875
CY2012Q1 topmd Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
23085179
CY2011Q1 topmd Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
8673800
topmd Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
23085175
CY2012Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8886000 ILS
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8527000 ILS
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
394000 ILS
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
409000 ILS
CY2012Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
96000 ILS
CY2012Q1 us-gaap Assets
Assets
637000 ILS
CY2011Q4 us-gaap Assets
Assets
1565000 ILS
CY2012Q1 us-gaap Assets Current
AssetsCurrent
420000 ILS
CY2011Q4 us-gaap Assets Current
AssetsCurrent
1340000 ILS
CY2012Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
217000 ILS
CY2011Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
225000 ILS
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 63pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> NOTE 3:-</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <table style="TEXT-ALIGN: justify; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="TEXT-ALIGN: justify" valign="top"> <td style="TEXT-ALIGN: justify; WIDTH: 9pt">&nbsp;</td> <td style="TEXT-ALIGN: justify; WIDTH: 18pt"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> a.&nbsp;</div> </td> <td style="TEXT-ALIGN: justify"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> In March, 2012, the Company issued 1,271,597 ordinary shares of $0.001 par value each, as part of financing round in an aggregated amount of NIS 1,234 thousands (NIS 1,130 thousands were received prior to December 31, 2011 and were also presented in the Financial statement of December 31, 2011, as part of the Additional paid-in capital. The Company also issued 186,902 Ordinary Shares in lieu of repayments of debts in the aggregate amount of NIS 165 thousands.</div> </td> </tr> </table> </div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"> <br /> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> <table style="TEXT-ALIGN: justify; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="TEXT-ALIGN: justify" valign="top"> <td style="TEXT-ALIGN: justify; WIDTH: 9pt">&nbsp;</td> <td style="TEXT-ALIGN: justify; WIDTH: 18pt"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> b.&nbsp;</div> </td> <td style="TEXT-ALIGN: justify"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> On March 1, 2012,("Approval date")&nbsp;&nbsp;the Company&#39;s shareholders meeting approved a Grant of 62,500 non-listed company options, which can be materialized to 62,500 Company&#39;s ordinary stock of $ 0.001 par value each, for each of the Company&#39;s five Directors. The granted options Fair Value estimated on the Approval date according to the Binomial model. The parameters being used for the calculation are: risk-free interest of 4.99%, Dividend yield 0%, expected volatility 71.02%, stock price NIS 1.6 and term life of 10 years. The options aggregated Fair value of these options accumulated to NIS 332 in thousands, and is recognized over the vesting period.</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The options described above have not been issued as of the date of the Financial Statement.</div> <!--EndFragment--></div> </div>
CY2012Q1 us-gaap Business Acquisition Cost Of Acquired Entity Cash Paid
BusinessAcquisitionCostOfAcquiredEntityCashPaid
ILS
CY2011Q4 us-gaap Business Acquisition Cost Of Acquired Entity Cash Paid
BusinessAcquisitionCostOfAcquiredEntityCashPaid
595000 ILS
CY2011Q1 us-gaap Business Acquisition Cost Of Acquired Entity Cash Paid
BusinessAcquisitionCostOfAcquiredEntityCashPaid
ILS
CY2012Q1 us-gaap Business Acquisition Cost Of Acquired Entity Equity Interests Issued And Issuable
BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable
ILS
CY2011Q4 us-gaap Business Acquisition Cost Of Acquired Entity Equity Interests Issued And Issuable
BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable
-1186000 ILS
CY2011Q1 us-gaap Business Acquisition Cost Of Acquired Entity Equity Interests Issued And Issuable
BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable
ILS
CY2012Q1 us-gaap Business Acquisition Cost Of Acquired Entity Purchase Price
BusinessAcquisitionCostOfAcquiredEntityPurchasePrice
ILS
CY2011Q4 us-gaap Business Acquisition Cost Of Acquired Entity Purchase Price
BusinessAcquisitionCostOfAcquiredEntityPurchasePrice
1781000 ILS
CY2011Q1 us-gaap Business Acquisition Cost Of Acquired Entity Purchase Price
BusinessAcquisitionCostOfAcquiredEntityPurchasePrice
ILS
CY2012Q1 us-gaap Business Acquisition Purchase Price Allocation Current Assets Prepaid Expense And Other Assets
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets
ILS
CY2011Q4 us-gaap Business Acquisition Purchase Price Allocation Current Assets Prepaid Expense And Other Assets
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets
-818000 ILS
CY2011Q1 us-gaap Business Acquisition Purchase Price Allocation Current Assets Prepaid Expense And Other Assets
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets
ILS
CY2012Q1 us-gaap Business Acquisition Purchase Price Allocation Current Liabilities Other Liabilities
BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesOtherLiabilities
ILS
CY2011Q4 us-gaap Business Acquisition Purchase Price Allocation Current Liabilities Other Liabilities
BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesOtherLiabilities
-978000 ILS
CY2011Q1 us-gaap Business Acquisition Purchase Price Allocation Current Liabilities Other Liabilities
BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesOtherLiabilities
ILS
CY2012Q1 us-gaap Business Acquisition Purchase Price Allocation Deferred Income Taxes Asset Liability Net
BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNet
ILS
CY2011Q4 us-gaap Business Acquisition Purchase Price Allocation Deferred Income Taxes Asset Liability Net
BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNet
1351000 ILS
CY2011Q1 us-gaap Business Acquisition Purchase Price Allocation Deferred Income Taxes Asset Liability Net
BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNet
ILS
CY2012Q1 us-gaap Business Acquisition Purchase Price Allocation Other Noncurrent Assets
BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentAssets
ILS
CY2011Q4 us-gaap Business Acquisition Purchase Price Allocation Other Noncurrent Assets
BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentAssets
270000 ILS
CY2011Q1 us-gaap Business Acquisition Purchase Price Allocation Other Noncurrent Assets
BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentAssets
ILS
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90000 ILS
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
929000 ILS
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
922000 ILS
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105000 ILS
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7000 ILS
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-839000 ILS
CY2011Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-817000 ILS
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
90000 ILS
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23814428
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22355929
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23814428
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22355929
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
93000 ILS
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
87000 ILS
CY2011 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
ILS
CY2012Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
165000 ILS
CY2011Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
ILS
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
165000 ILS
CY2011 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
858000 ILS
CY2012Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
ILS
CY2011Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
ILS
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
858000 ILS
CY2012Q1 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
1313000 ILS
CY2011Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
1351000 ILS
CY2011 us-gaap Depreciation
Depreciation
43000 ILS
CY2012Q1 us-gaap Depreciation
Depreciation
13000 ILS
CY2011Q1 us-gaap Depreciation
Depreciation
8000 ILS
us-gaap Depreciation
Depreciation
105000 ILS
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.1
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.06
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.2
CY2012Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
127000 ILS
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
132000 ILS
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
546000 ILS
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1178000 ILS
CY2011Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
121000 ILS
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3141000 ILS
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-110000 ILS
CY2012Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-72000 ILS
CY2011Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-183000 ILS
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
137000 ILS
CY2011 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
ILS
CY2012Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-38000 ILS
CY2011Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
ILS
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-38000 ILS
CY2011 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
ILS
CY2012Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
90000 ILS
CY2011Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
ILS
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
90000 ILS
CY2011 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-15000 ILS
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
70000 ILS
CY2012Q1 us-gaap Interest Payable Current
InterestPayableCurrent
404000 ILS
CY2011Q4 us-gaap Interest Payable Current
InterestPayableCurrent
386000 ILS
CY2012Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
313000 ILS
CY2011Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-41000 ILS
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
437000 ILS
CY2011 us-gaap Increase Decrease In Postemployment Obligations
IncreaseDecreaseInPostemploymentObligations
-71000 ILS
CY2012Q1 us-gaap Increase Decrease In Postemployment Obligations
IncreaseDecreaseInPostemploymentObligations
ILS
CY2011Q1 us-gaap Increase Decrease In Postemployment Obligations
IncreaseDecreaseInPostemploymentObligations
5000 ILS
us-gaap Increase Decrease In Postemployment Obligations
IncreaseDecreaseInPostemploymentObligations
2000 ILS
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24000 ILS
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-81000 ILS
CY2011Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
159000 ILS
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
76000 ILS
CY2011 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
70000 ILS
CY2012Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
ILS
CY2011Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
ILS
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
637000 ILS
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1565000 ILS
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3061000 ILS
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2933000 ILS
CY2012Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
185000 ILS
CY2011Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
177000 ILS
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1947000 ILS
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
104000 ILS
CY2011Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
ILS
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10102000 ILS
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
ILS
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5000 ILS
CY2011Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
ILS
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-321000 ILS
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1940000 ILS
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-938000 ILS
CY2011Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-817000 ILS
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9691000 ILS
us-gaap Net Income Loss
NetIncomeLoss
-1053000 ILS
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-1646000 ILS
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-1715000 ILS
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-4703000 ILS
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-1042000 ILS
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-1429000 ILS
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-489000 ILS
us-gaap Net Income Loss
NetIncomeLoss
-11588000 ILS
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
238000 ILS
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
46000 ILS
CY2011Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
30000 ILS
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-260000 ILS
CY2011 us-gaap Operating Expenses
OperatingExpenses
1280000 ILS
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
1475000 ILS
CY2011Q1 us-gaap Operating Expenses
OperatingExpenses
519000 ILS
us-gaap Operating Expenses
OperatingExpenses
11328000 ILS
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-1280000 ILS
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1475000 ILS
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-519000 ILS
us-gaap Operating Income Loss
OperatingIncomeLoss
-11328000 ILS
CY2012Q1 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
1217000 ILS
CY2011Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
1064000 ILS
CY2011 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
310000 ILS
CY2012Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8000 ILS
CY2011Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-42000 ILS
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-97000 ILS
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
ILS
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000 ILS
CY2011Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
ILS
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
321000 ILS
CY2012Q1 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
2000 ILS
CY2011Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
2000 ILS
CY2012Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
330000 ILS
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
411000 ILS
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
ILS
CY2012Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
104000 ILS
CY2011Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
ILS
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4690000 ILS
CY2011 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
ILS
CY2012Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
ILS
CY2011Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
ILS
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1870000 ILS
CY2011 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
1352000 ILS
CY2012Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
ILS
CY2011Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
ILS
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
1352000 ILS
CY2011 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
ILS
CY2012Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
ILS
CY2011Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
ILS
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1595000 ILS
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
217000 ILS
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
225000 ILS
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
734000 ILS
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
297000 ILS
CY2011Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
398000 ILS
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8187000 ILS
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11588000 ILS
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10159000 ILS
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
-481000 ILS
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
96000 ILS
CY2011Q1 us-gaap Share Based Compensation
ShareBasedCompensation
ILS
us-gaap Share Based Compensation
ShareBasedCompensation
1073000 ILS
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
-2609000 ILS
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-1545000 ILS
CY2007Q1 us-gaap Stockholders Equity
StockholdersEquity
ILS
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
928000 ILS
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
2281000 ILS
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
566000 ILS
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-175000 ILS
CY2010 us-gaap Stockholders Equity Other
StockholdersEquityOther
3346000 ILS
CY2011Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
858000 ILS
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1981000 ILS
CY2008 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2605000 ILS
CY2012Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
269000 ILS
CY2010 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
207000 ILS
CY2012Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
183000 ILS
CY2011Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
175000 ILS

Files In Submission

Name View Source Status
0001178913-12-001510-index-headers.html Edgar Link pending
0001178913-12-001510-index.html Edgar Link pending
0001178913-12-001510.txt Edgar Link pending
0001178913-12-001510-xbrl.zip Edgar Link pending
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
exhibit_32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
topmd-20120331.xml Edgar Link completed
topmd-20120331.xsd Edgar Link pending
topmd-20120331_cal.xml Edgar Link unprocessable
topmd-20120331_def.xml Edgar Link unprocessable
topmd-20120331_lab.xml Edgar Link unprocessable
topmd-20120331_pre.xml Edgar Link unprocessable
zk1211466.htm Edgar Link pending